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The precise control of miR-1792 microRNA
(miRNA) is essential for normal development, and
overexpression of certain miRNAs from this cluster
is oncogenic. Here, we find that the relative expres-
sion of the six miRNAs processed from the primary
(pri-miR-1792) transcript is dynamically regulated
during embryonic stem cell (ESC) differentiation.
Pri-miR-1792 is processed to a biogenesis inter-
mediate, termed ‘‘progenitor-miRNA’’ (pro-miRNA).
Pro-miRNA is an efficient substrate for Micropro-
cessor and is required to selectively license produc-
tion of pre-miR-17, pre-miR-18a, pre-miR-19a, pre-
miR-20a, and pre-miR-19b from this cluster. Two
complementary cis-regulatory repression domains
within pri-miR-1792 are required for the blockade
of miRNA processing through the formation of an
autoinhibitory RNA conformation. The endonuclease
CPSF3 (CPSF73) and the spliceosome-associated
ISY1 are responsible for pro-miRNA biogenesis and
expression of all miRNAs within the cluster except
miR-92. Thus, developmentally regulated pro-miRNA
processing is a key step controlling miRNA expres-
sion and explains the posttranscriptional control of
miR-1792 expression in development.INTRODUCTION
MicroRNAs (miRNAs) are a large family of regulatory RNAs that
inhibit target expression by base pairing with complementary
sites in the 30 untranslated region (30 UTR) to promote mRNA
decay and translational repression (Bartel, 2009). Canonical
miRNA biogenesis involves the two-step processing of long pri-
mary miRNA transcripts (pri-miRNAs) by the Microprocessor,
comprising the ribonuclease DROSHA and its essential co-fac-
tor DGCR8, to generate 50–70 nucleotide (nt) precursor miRNA
(pre-miRNA) intermediates that are processed by DICER to
mature 22 nucleotide miRNAs (Ha and Kim, 2014). Individual
pri-miRNA can be expressed from distinct miRNA loci, or from
introns or exons of protein coding genes. Furthermore somepri-miRNAs contain a single miRNA whereas others contain
clusters of several miRNAs. Regardless, Microprocessor recog-
nizes the hairpin structures in the pri-miRNA through the stem-
loop and the stem-loop-single-stranded RNA (ssRNA) junction
and specifically cleaves the double stranded RNA stem to
release the 50 and 30 flanking segments and generate pre-
miRNAs that are substrates for DICER processing (Ha and
Kim, 2014).
miRNAs play critical roles in development and their dysregula-
tion causes disease (Di Leva and Croce, 2010; Lin and Gregory,
2015; Mendell and Olson, 2012). It is increasingly well appreci-
ated that posttranscriptional mechanisms play an important
role controlling miRNA expression (Siomi and Siomi, 2010).
Several Microprocessor or Dicer accessory factors and inhibi-
tory proteins have been identified that either facilitate or inhibit
distinct subsets of miRNAs. The activity of some of these factors
is linked with cell-signaling pathways to afford dynamic control
of the miRNA biogenesis machinery (Mori et al., 2014; Siomi
and Siomi, 2010). Perturbation of these pathways can be onco-
genic. One example is the posttranscriptional control of let-7
miRNA expression by the RNA-binding protein LIN28 (Thornton
and Gregory, 2012).
To investigate how expression of other miRNAs might be
regulated, we focused on the polycistronic miR-1792. Pri-
miR-1792 encodes six (miR-17, miR-18a, miR-19a, miR-20a,
miR-19b-1, and miR-92a) mature miRNAs. Haploinsufficiency
of this locus causes the Feingold syndrome of microcephaly,
short stature, and digital abnormalities in human patients and
mouse models, whereas ablation of this locus in mouse causes
perinatal lethality with heart, lung, and B cell defects (Concep-
cion et al., 2012; de Pontual et al., 2011; Mendell, 2008; Ventura
et al., 2008). Conditional mouse knockouts highlight the impor-
tance of these miRNAs for kidney development and function
and neural stem cell biology (Bian et al., 2013; Marrone et al.,
2014; Patel et al., 2013). Gene amplification and increased
expression of miRNAs from this cluster is observed in numerous
types of cancer compared to normal tissues, and transgenic
overexpression of this ‘‘OncomiR-1’’ promotes B cell lymphoma,
T cell acute lymphoblastic leukemia (T-ALL), and retinoblastoma
in mice (Conkrite et al., 2011; He et al., 2005; Mavrakis et al.,
2010; Nittner et al., 2012; Sandhu et al., 2013). Individual miRNAs
within this cluster promote cell proliferation, inhibit apoptosis,
inhibit differentiation, and promote angiogenesis, to drive tumor-
igenesis (Mendell, 2008; Mu et al., 2009; Olive et al., 2009).Cell 162, 885–899, August 13, 2015 ª2015 Elsevier Inc. 885
Figure 1. Posttranscriptional Regulation of miR-1792
(A) qRT-PCR analysis of miRNA and pri-miRNA expression in mouse ESCs over a differentiation time course. Data normalized to snoR142 (for miRNAs) and
ACTIN (for pri-miRNA) and represented as mean ± SEM. *p < 0.05, **p < 0.01, Student’s t test.
(B) Northern blot analysis of the RNAs from (A) using probes to detect the indicated miRNAs. U6 was used as control.
(C) Relative read number of small RNA sequences mapping to the indicated miRNAs in ESCs. RPM, reads per million.
(D) Mapping of RNA-seq cDNA sequence to the mouse miR-1792 locus. cDNAs were prepared and sequenced fromWT, Dgcr8/, and Dicer/ ESCs. Exon-
exon boundaries and read numbers from sequencing data are shown (Red). TopHat (http://ccb.jhu.edu/software/tophat/index.shtml) was used for the analysis.
(E) Schematic representation of the mouse miR-1792 locus. P1, P2, P3, and P4 indicate the probes used for northern blots in (F). RP1 and RP2 indicate the
position of the primers used for the 50 RACE experiments presented in (G). Sequence of exon 3 (shaded gray) includes the position of the cleavage site identified
by 50 RACE (green font) and the miR-17-5p sequence (red font).
(legend continued on next page)
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Moreover, while expression of miR-19, promotes lymphoma in
mouse, co-expression of miR-92 suppresses this oncogenic ac-
tivity (Olive et al., 2013). The miR-19:miR-92 expression ratio in
Myc-induced mouse tumors appears to be dynamically regu-
lated during lymphoma progression (Olive et al., 2013). Similarly,
whereas ectopic expression of the entire miR-1792 cluster can
result in the expansion of apparently normal multipotent hemato-
poietic progenitors, the imbalanced expression of miR-19 or
miR-92 results in B cell hyperplasia and erythroleukemia,
respectively (Li et al., 2012). Co-expression of miR-17 sup-
pressed themiR-92 oncogenic effects in this context. Consistent
with these mouse models, elevated miR-92 and decreased miR-
17 expression was observed in B cell chronic lymphocytic leuke-
mia patients with an aggressive clinical phenotype (Li et al.,
2012). Taken together, the precise regulation of this miRNA clus-
ter, and importantly, the relative expression of individual miRNAs
from within this cluster are critical for development and disease
yet the mechanisms that control miR-1792 biogenesis remain
largely unknown (Guil and Ca´ceres, 2007; O’Donnell et al., 2005).
Here, we find expression of individual miRNAs from pri-miR-
1792 to be dynamically regulated during embryonic stem cell
(ESC) differentiation. We describe a new paradigm for miRNA
regulation in which certain sequences (repression domains)
within the pri-miR-1792 are involved in the formation of a
higher-order RNA conformation that selectively inhibits Micro-
processor-mediated production of pre-miR-17, pre-miR-18a,
pre-miR-19a, pre-miR-20a, and pre-miR-19b, from this cluster.
Cleavage of pri-miR-1792 to remove the autoinhibitory 50
fragment produces a miRNA biogenesis intermediate that we
termed ‘‘progenitor-miRNA’’ (pro-miRNA). Pro-miRNA biogen-
esis is dynamically regulated and specifically requires the endo-
nuclease component of the cleavage and polyadenylation
specificity factor complex, CPSF3 (also known as CPSF73 or
CPSF-73) (Mandel et al., 2006), as well as the poorly character-
ized spliceosome factor ISY1. These factors are selectively
required for the expression of all miRNAs within the cluster
except for miR-92. Thus, developmentally regulated generation
of pro-miRNA explains the posttranscriptional control of miR-
1792 expression. Our findings challenge the current two-step
processing model for miRNA biogenesis and add an additional
processing step upstream of Microprocessor that can be
dynamically regulated for precise miRNA control.
RESULTS
miR-1792 Expression Is Regulated
Posttranscriptionally during ESC Differentiation
To investigate possible miR-1792 regulatory mechanisms, we
analyzed miRNA expression during ESC differentiation. As a
control we monitored levels of let-7 miRNA that accumulates
during the later stages of cell differentiation (Viswanathan
et al., 2008). While miR-92 expression was relatively constant
throughout the differentiation time course and correlated quite(F) Northern blots performed on indicated RNAs. Probes are indicated (left) and
(G) 50 RACE data from Dicer/ ESCs using the indicated primers. Ethidium bromi
sequencing data (right). The numbers indicate the proportion of all sequences th
red, and miR-17-3p and miR-92a-1* are highlighted in blue.well with expression of pri-miR-1792, the relative expression
of the other miRNAs from this locus was more dynamic with a
peak inmiR-17,miR-18a,miR-19a,miR-20a, andmiR-19b levels
observed around days 2–3 of differentiation (Figures 1A and 1B).
Analysis of our small RNA cloning and high-throughput cDNA
sequencing data from ESCs revealed a strong predominance
of miR-92 sequences compared to other miRNAs in this cluster
(Figure 1C). As a first step to investigate the possible mecha-
nisms for this developmentally regulated, posttranscriptional
control of miR-1792, we performed RNA cloning and high-
throughput cDNA sequencing from ESCs to define the pri-
miRNA. Since most pri-miRNAs are present at very low levels
in steady state RNA, we included Dgcr8 (and Dicer) knockout
ESCs in this analysis. The sequencing data fromDgcr8 knockout
ESCs indicated that themouse pri-miR-1792 gene spansmore
than 5 kb and contains multiple introns. The miRNA sequences
themselves are located within Intron 3 of the host transcript,
similar to the annotated human gene (Figures 1D and 1E).
Increased read abundance extended across the entire cluster
in Dgcr8 knockout compared to the wild-type cells suggesting
that this region contains the Microprocessor substrate RNA
that is stabilized in Dgcr8-deficient cells. We also detected an
increased number of reads mapping downstream of the miRNA
cluster in the Dicer knockout ESCs. This polyadenylated 30 RNA
fragment likely represents a product of Microprocessor-medi-
ated cleavage of pre-miR-92. The elevated abundance of this
30 RNA fragment in Dicer knockout cells was confirmed by quan-
titative RT-PCR (qRT-PCR) (data not shown) and is consistent
with a feedback mechanism leading to increased pri-miR-
1792 expression in the absence of the functional mature
miRNAs. Altogether, these results reveal that miR-1792
miRNAs are embedded in a long, spliced, polyadenylated pri-
miRNA expressed from a locus of >5 kb, and the processing
and/or stability of the mature miRNAs expressed from this clus-
ter can be dynamically regulated.
Identification of a Processed Pri-miR-1792
Intermediate
To validate pri-miRNA sequencing data, we performed northern
blots with probes spanning the locus (Figure 1E). We included
total RNA, as well as RNA separated into the PolyA(+) and
PolyA() fractions prepared from wild-type, Dgcr8-, and Dicer-
knockout mESCs. A large (>5 kb) transcript was detected in
the Dgcr8 knockout RNA samples in both total RNA as well as
PolyA(+) RNA with all probes (P1–P4) tested. This likely corre-
sponds to the full-length primary transcript (Figure 1F) and
supports the RNA sequencing results. This analysis also identi-
fied (with probes P1 and P2) an additional prominent band
of 2.5 kb that was detected in the total and PolyA() RNAs
from wild-type and Dicer/ ESCs that corresponds to a 50
RNA fragment containing Introns 1 and 2 (and likely also Exons
1 and 2). Strikingly, probe 3 (P3), that spans the miRNA se-
quences in Intron 3, detected a predominant band of 800 ntthe schematic (right) represents an interpretation of the northern blot data.
de-stained agarose gel analysis of RACE products (left) and summary of RACE
at map to a particular nucleotide. Mature miRNA sequences are highlighted in
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in the total and PolyA- RNAs (Figure 1F). Finally, a probe comple-
mentary to sequences in the 30 region detected 2.2 kb band
only in the total and PolyA(+) RNA and not in the PolyA() RNA
from Dicer/ cells. Altogether, these results support that
the polyadenylated pri-miRNA, detectable in Dgcr8/ cells,
is >5 kb, and this pri-miR-1792 is cleaved into three major frag-
ments: 2.5 kb 50 region, 800 nt region containing miRNA se-
quences, and 2.2 kb 30 region with a PolyA tail.
50 Rapid amplification of cDNA ends (50 RACE) using the indi-
cated primers (Figure 1G) revealed that the majority of the 50
ends of the polyadenylated 30 region map to the expected
Drosha cleavage site for the biogenesis of miR-92a with the
remainder of reads corresponding to Drosha cleavage of pre-
miR-19b. However, the 50 cleavage site occurs 9 nt upstream
of the miR-17-5p sequence and is inconsistent with the ex-
pected Drosha cleavage. Taken together, these results indicate
that the pri-miR-1792 is specifically cleaved close to the pre-
miR-17 hairpin by an unknown nuclease to release a 50 upstream
RNA fragment and that Drosha processing of pre-miR-92 gener-
ates the 30 cleavage to liberate a ‘‘progenitor-miRNA’’ (pro-
miRNA) intermediate containing miR-17, miR-18a, miR-19a,
miR-20a, and miR-19b.
The 50 Fragment of Pri-miR-1792 Inhibits
Microprocessor Activity
To examine whether the pro-miRNA might represent a miRNA
biogenesis intermediate, we tested different RNA substrates in
Microprocessor assays. The pri-miRNA sequence used in these
experiments corresponds to a genomic DNA sequence begin-
ning at the 50 end of Exon 2 and ending at the 30 end of Exon 6
(Figure 1E). The pro-miRNA starts at the 50 side of pre-miR-17
and ends 50 nt downstream of the 30 end of pre-miR-92. The
pro-miRNA+50F and pro-miRNA+30F include the pro-miRNA
with the additional upstream or downstream sequences present
in the pri-miRNA, respectively. These in vitro processing assays
revealed that pro-miRNA is a preferential Microprocessor sub-
strate compared to pri-miRNA, and the 50 region of the pri-
miR-1792 inhibits Microprocessor (Figure 2A).
Cleavage of Pri-miR-1792 to Pro-miRNA Is a Key Step
in miRNA Maturation
To explore the functional impact of pro-miRNA biogenesis, we
performed rescue experiments in mouse ESCs in which the
endogenous miR-1792 is deleted. miR-1792/ ESCs were
transfected with plasmids expressing either the wild-type pri-
miR-1792 or a mutant version in which two nucleotides (AG)
at the potential cleavage site were mutated. qRT-PCR analysis
indicated that both plasmids produced similar levels of pri-
miRNA (Figure 2B) yet when PCR primers spanning the cleavage
site were used a strong accumulation of the uncleaved RNA was
detected supporting that the mutation inhibits pri-miRNA cleav-
age (Figure 2B). Northern blot analysis detected a cleaved 50
fragment specifically in cells expressing the wild-type plasmid
(Figure 2C). We next examined the consequence of this cleavage
site mutation on mature miRNA biogenesis. Analysis of miRNA
expression by qRT-PCR and by northern blot revealed that the
AG-CC mutation inhibits expression all miRNAs in the cluster
except for miR-92 (Figure 2D and 2E). Since the plasmid ex-888 Cell 162, 885–899, August 13, 2015 ª2015 Elsevier Inc.pressing pro-miR-1792 also contains a small amount of
upstream sequence that includes the cleavage site, we could
also test the effect of the same AG-CC mutation in this context.
The AG-CC mutation had no effect on miRNA biogenesis ex-
pressed from the pro-miR-1792 plasmid (Figures 2D and 2E).
Next, to examine whether pro-miRNA biogenesis is an important
step for the expression of endogenous miRNAs, we used
CRISPR/Cas9 technology to engineer the AG-CC mutation at
the pri-miR-1792 locus in ESCs. Introduction of this mutation
led to dramatically diminished expression of miR-17, miR-18a,
miR-19a, miR-20a, and miR-19b compared to wild-type cells
but had no effect on endogenousmiR-92 expression (or an unre-
lated control miRNA, miR-21) (Figure 2F). These results suggest
that the 50 region of pri-miR-1792 inhibits production of most
miRNAs in this cluster except for miR-92 and that this autoinhi-
bitory mechanism might explain the posttranscriptional regula-
tion of pri-miR-1792 expression that we observed in ESCs
(Figure 1A).
Since the 50 RACE strategy could not accurately distinguish
whether cleavage occurred after the A or the G nucleotides in
the pri-miR-1792 (due to the dCTP 30 tailing of the cDNA with
terminal deoxynucleotidyl transferase and use of complemen-
tary oligo-G containing PCR primer), we performed additional
mutagenesis at the cleavage site and examined the effects on
miRNA expression. This revealed that mutation of the G nucleo-
tide had no impact on miR-1792 whereas the A mutation (as
well asmutation of the preceding C nucleotide) dramatically sup-
pressed miRNA expression comparable to the AG mutant (Fig-
ure S1). Together, these results demonstrate that cleavage of
the autoinhibitory 50 RNA fragment to generate pro-miRNA is
an obligate step for the biogenesis of miRNAs from the pri-
miR-1792.
Identification of Two Complementary Repression
Domains that Control miRNA Biogenesis
To define the cis-regulatory RNA sequences present in the 50
fragment of pri-miR-1792, additional genetic rescue experi-
ments were performed using a panel of pri-miR-1792 expres-
sion constructs in which portions of the 50 inhibitory fragment
are deleted. This identified a domain 80–120 nt upstream
of the cleavage site responsible for the selective miRNA repres-
sion (Figure 3A). This was confirmed by similar experiments
in which only the 40 nt repression domain (RD) was deleted in
the context of the pro-miR-1792 containing the 50 fragment
(Figure 3B). To further examine the function of the RD, we
performed in vitro Microprocessor assays. To distinguish pro-
cessing of the individual pre-miRNAs from the cluster, we
performed Microprocessor assays using non-radiolabeled sub-
strate RNAs and visualized pre-miRNAs by northern blot. This
confirmed that the 40 nt RD within the 50 region of pri-miR-
1792 selectively inhibits the processing of pre-miR-17, pre-
miR-18, pre-miR-19, and pre-miR-20 from the cluster but has
no inhibitory effect on the processing of pre-miR-92 (Figure 3C).
Altogether, these results suggest that the RD in the 50 region of
pri-miR-1792 inhibits production ofmostmiRNAs in this cluster
except for miR-92 and that this autoinhibitory mechanism might
explain the posttranscriptional regulation of pri-miR-1792
expression.
Figure 2. Cleavage of Pri-miR-1792 to Pro-miRNA Is a Key Step in miRNA Maturation
(A) Microprocessor cleavage assays performed using the indicated substrates. Asterisk denotes a truncated or non-specific RNA.
(B) qRT-PCR analysis of the relative expression of regions of miR-1792 expressed from the indicated plasmids. Primers amplifying the 50 upstream sequence
(50) and primers spanning the cleavage site (CS) were used to detect pri-miR-1792 in transfected miR-1792/ ESCs. Data normalized to ACTIN and rep-
resented as mean ± SEM. **p < 0.01, Student’s t test.
(C) Northern blot analysis of the RNA samples in (B) using a probe that detects the 50 upstream region of pri-miR-1792 (P2).
(D) miR-1792/ ESCs were transfected with the indicated rescue plasmids and mature miRNAs measured by qRT-PCR. Data normalized to snoR142 and
represented as mean ± SEM. **p < 0.01, Student’s t test.
(E) Northern blot analysis of the RNAs from (D) using probes to detect the indicated miRNAs.
(F) qRT-PCR analysis of the indicated endogenous mature miRNAs expression in ESCs engineered with a mutation in the cleavage site at the endogenous pri-
miR-1792 locus. Data are normalized to snoR142 and represented as mean ± SEM.
See also Figure S1.We considered that the RDmight impact the secondary struc-
ture of this pri-miRNA cluster to suppress Microprocessor activ-
ity. The secondary structure of pri-miR-17-92 containing the
minimal RD was computationally predicted using the RNAFold
algorithm (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). This
indicated that the RD might base-pair with a highly conserved
sequence that we termed repression domain* (RD*) that is
located between pre-miR-19b and pre-miR-92 (Figures 3D, 3E,
and S2). We found this intriguing since this complementary
RD* is located at the boundary of the miRNAs whose processing
is suppressed miR-92 that escapes repression. The ability of RDand RD* sequences to form a duplex was experimentally
confirmed (Figure 3E), and genetic rescue experiments with
plasmids lacking the RD* revealed the requirement of this region
for miRNA repression (Figures 3B and 3F). Deletion of the RD or
the RD* had a similar effect onMicroprocessor activity indicating
that both domains are important for the autoinhibition of miRNA
biogenesis (Figure 3G). To test the model that base-paring
between the RD and RD* is important for miRNA regulation, we
generated expression plasmids with either the RD or RD*
mutated. Individual RD or RD* mutations led to elevated miRNA
expression, whereas combining the compensatory mutationsCell 162, 885–899, August 13, 2015 ª2015 Elsevier Inc. 889
Figure 3. Identification of Two Complementary Repression Domains Controlling miRNA Biogenesis
(A and B) Genetic rescue experiments in whichmiR-1792/ ESCs were transfected with the indicated rescue plasmids andmaturemiRNAsmeasured by qRT-
PCR. The 40 nt repression domain (RD) is highlighted with blue shading in (A). Data normalized to snoR142 and represented as mean ± SEM. **p < 0.01,
Student’s t test.
(C) In vitro Microprocessor assays with non-radiolabeled substrate RNAs. Aliquots of the reaction were loaded onto multiple gels, transferred to nylon mem-
branes, and individual pre-miRNAs detected by northern blot using the indicated probes.
(D) Secondary structure prediction of theminimal pri-miRNA fragment containing the 50 repression domain (RD) using the RNAFold algorithm (http://rna.tbi.univie.
ac.at/cgi-bin/RNAfold.cgi). The region (termed RD*) that is complementary to the RD is depicted. RD*, repression domain star.
(legend continued on next page)
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that restored base-pairing between RD and RD* reestablished
miRNA repression (Figure 3H).
Pri-miR-1792 Adopts an RNA Conformation that
Inhibits Microprocessor
To gain insight into the mechanism by which pri-miR-1792
processing might be regulated, we tested the possible involve-
ment of RNA conformational changes mediated by the RD
and RD*. The extent to which Microprocessor was selectively
inhibited was found to be sensitive to RNA annealing in the
presence of MgCl2—a result that further implicated RNA confor-
mation in miRNA repression (Figure 4A). We next analyzed the
differential RNase T1 accessibility of pro-miR-1792 with or
without the 50 fragment. This revealed that the 50 fragment
confers striking resistance to nuclease digestion, further sup-
porting that the pro-miR-1792 containing the 50 fragment
adopts a compacted conformation (Figure 4B). To gain direct
evidence that the pri-miRNA containing the 50 RD adopts a
distinct conformation, we used electron microscopy to directly
visualize the higher order structure of different RNAs. This
analysis revealed that a pri-miR-1792 fragment containing
both the RD and RD* forms highly compacted, circular
particles 12 nM in diameter whereas RNAs lacking either the
RD or the RD* did not form particles under the same conditions
(Figures 4C and 4D). Altogether, these results uncover an
important role for the RD and the RD* in the dynamic control
of pri-miR-1792 biogenesis through the formation of a com-
pacted RNA conformation that is refractory to cleavage by
Microprocessor.
CPSF3 Endonuclease Is Required for Pro-miRNA
Biogenesis and miRNA Expression
To identify protein factors that might be involved in pro-miRNA
biogenesis and the posttranscriptional regulation of miR-
1792 expression, we performed RNA affinity purification using
both pri-miR-1792 and pro-miR-1792 RNA sequences and
identified associated proteins by mass spectrometry. Several
RNA-binding proteins including DGCR8 were identified in both
RNA purifications, whereas other proteins were found exclu-
sively in the pri-miR-1792 purification—the majority of which
fall into two main categories, factors involved in pre-mRNA 30
end cleavage and splicing regulators (Figure 5A). Since the
cleavage and polyadenylation specificity factor (CPSF) complex
possesses ribonuclease activity, we initially focused on the
possible role of components of this complex in miR-1792
biogenesis. We used siRNAs to knockdown CPSF2 (also known
as CPSF-100), CPSF3 (also known as CPSF-73), CSTF2 (CstF-
64), CSTF2T (TCstF-64), or FIP1L1 in ESCs and examined the
effects on mature miRNA expression. We found CPSF3, but
not CPSF2 or other mRNA cleavage/polyadenylation factors(E) A zoomed-in view of the base-pairing between RD and RD*. Inset shows th
sequences.
(F) Genetic rescue with the indicated plasmids and mature miRNAs measured by
*p < 0.05, **p < 0.01, Student’s t test.
(G) Microprocessor cleavage assays.
(H) As in (B) and (F) but using plasmids with the indicated nucleotide substitution
See also Figure S2.tested, is specifically required for expression of all the miRNAs
in the cluster except for miR-92 (Figures 5B–5D and S3). As a
positive control, DGCR8-depletion decreased expression of all
miRNA tested. Moreover, northern blot analysis revealed that
CPSF3 (but not CPSF2) is required for pro-miR-1792 biogen-
esis (Figure 5E). These experiments were performed in Dicer/
ESCs since the level of pri-miR-1792 is elevated in these cells.
Genetic rescue of miR-1792/ ESCs with miRNA expression
plasmids revealed that CPSF3 is specifically required for miRNA
expression from the pri-miRNA containing the 50 region and not
from the pro-miRNA (Figure 5F). Considering the established role
of CPSF3 as the endonuclease responsible for the cleavage of
the 30 end of both pre-mRNA and histone mRNA, as well as
the known CPSF3-mediated cleavage at ‘‘CA’’ dinucleotides,
we hypothesized that CPSF3 might be the endonuclease that
cleaves pri-miRNA-1792 to remove the RD and license Micro-
processor activity (Dominski et al., 2005; Mandel et al., 2006). To
directly test this, we generated recombinant CPSF3 (rCPSF3)
and a catalytic mutant (D75K/H76A) version of CPSF3 purified
from Escherichia coli and performed in vitro cleavage assays us-
ing different RNA substrates. We found that a fragment of pri-
miR-1792 containing the 50 repression domain, cleavage site,
and the entire pre-miR-17 sequence is specifically cleaved by
rCPSF3, whereas a slightly truncated RNA that lacks the pre-
miR-17 stem loop was not an efficient substrate (Figures 5G
and 5H). Mutation (AG-CC) at the cleavage site abolished
CPSF3-mediated pri-miRNA cleavage, and the catalytic mutant
CPSF3 was inactive in these assays (Figure 5I). We furthermore
found that addition of rCPSF3 to Microprocessor assays could
relieve the inhibition mediated by the 50 fragment of pri-miR-
1792 (Figure 5J). Altogether, these data strongly support our
model that CPSF3 is the nuclease responsible for specific pri-
miRNA cleavage to remove the repression domain and license
Microprocessor-mediated production of pre-miRNA from this
cluster.
Spliceosome Subunits Are Required for Pro-miRNA
Biogenesis and miRNA Expression
Considering our mass spectrometry data as well as a previous
report that found that processing the 30 end of histone pre-
mRNAs by CPSF3 requires components of the U7 snRNP we
next examined whether certain spliceosome subunits might
help recruit the CPSF3 endonuclease activity to pri-miR-1792
in vivo (Dominski et al., 2005). We initially focused on ISY1, a
poorly characterized homolog of the non-essential Isy1p protein
in yeast. Isy1p is a subunit of the NineTeen Complex and is
involved in the first step of splicing to control splicing fidelity
(Dix et al., 1999; Villa and Guthrie, 2005). We added to our char-
acterization, SF3B1, a component of the U2 small nuclear ribo-
nucleoprotein complex (U2 snRNP) that although not identifiede in vitro annealing and native PAGE analysis of synthetic RD and RD* RNA
qRT-PCR. Data are normalized to snoR142 and represented as mean ± SEM.
s (red font).
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Figure 4. Pri-miR-1792 Adopts an RNA Conformation that Inhibits Microprocessor
(A) Microprocessor cleavage assays performedwith (+) or without () RNA annealing in the presence of MgCl2. Reaction products were loaded ontomultiple gels
and analyzed by northern blot.
(B) RNase T1 accessibility assays performed using the indicated RNA and analyzed by reverse transcriptase primer extension using the indicated 50-end-labeled
primers.
(C) Negative-stain micrographs of indicated RNAs in the presence of MgCl2. Specimens were prepared in uranyl acetate. Lower panel shows representative
images of RD-Pro-RD* particles.
(D) 2D distribution of RD-Pro-RD* particles based on their diameter and circularities.in our mass spectrometric analysis of pri-miR-1792-associ-
ated proteins is a much more well characterized splicing factor.
We used siRNAs to individually knockdown ISY1 and SF3B1 in
ESCs and examined the effects on miRNA expression (Figures
6A–6C). This revealed that depletion of ISY1 or SF3B1 led to
diminished expression of all miRNAs in the pri-miR-1792 clus-
ter with the exception of miR-92 and a corresponding accumula-
tion of pri-miR-1792 (Figure 6B). Northern blots confirmed the892 Cell 162, 885–899, August 13, 2015 ª2015 Elsevier Inc.role of these splicing factors in pro-miRNA biogenesis (Fig-
ure 6D). RNAi knockdown of multiple additional spliceosomal
factors revealed a specific requirement for ISY1 as well as U2
snRNP components (SF3B1 and U2AF2) but not other splicing
factors associated with the second step of splicing including
PRPF4 (U4/U6 snRNP), SNRNP40 (U5 snRNP (Figure S4). These
findings help clarify the requirement of certain splicing factors
and strongly support our model that ISY1 together with ISY1
Figure 5. CPSF3 Endonuclease Is Required for Pro-miRNA Biogenesis and Mature miRNA Expression
(A) Summary of mass spectrometric analysis of RNA-affinity purifications. Factors known to be involved in pre-mRNA 30 cleavage and polyadenylation are
highlighted in red and proteins involved in splicing are listed in blue.
(B) Western blot of lysates prepared from ESCs transfected with the siRNAs and analyzed using the indicated antibodies.
(C) qRT-PCR analysis of pri-miRNA expression in cells with indicated siRNA knockdown. Data normalized to ACTIN and represented as mean ± SEM.
(D) qRT-PCR analysis of the indicated endogenous miRNAs in ESCs transfected with the siRNAs shown. Data normalized to snoR142 and represented as
mean ± SEM.
(E) Northern blot performed on total RNA, fromWT, Dgcr8/, and Dicer/ ESCs transfected with the indicated siRNAs. A probe was used to detect pro-miRNA
as indicated on the right (P3).
(F) qRT-PCR analysis of the relative expression the indicated miRNAs expressed from the indicated miR-1792 rescue plasmids co-transfected with the
indicated siRNAs. Data normalized to snoR142 and represented as mean ± SEM.
(G) Coomassie blue stained SDS-PAGE gel (top) and aCPSF3 western analysis (bottom) of recombinant His-CPSF3 purified from E. coli. Wild-type (WT) and a
catalytic mutant CPSF3 (D75K/H76A) were produced.
(H and I) CPSF cleavage assays using the indicated in vitro transcribed RNA substrate and His-CPSF3 (WT or Mutant).
(J) Microprocessor cleavage assay with the indicated RNA substrate and with addition of His-CPSF3 where indicated.
See also Figure S3.
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Figure 6. Spliceosome Subunits Are Required for Pro-miRNA Biogenesis and miRNA Expression
(A) Western blot of lysates prepared from ESCs transfected with the siRNAs and analyzed using the indicated antibodies.
(B) qRT-PCR analysis of pri-miRNA expression in cells with indicated siRNA knockdown. Data are normalized to ACTIN and represented as mean ± SEM.
(C) qRT-PCR analysis of the indicated endogenous miRNAs in ESCs transfected with the siRNAs shown. Data are normalized to snoR142 and represented as
mean ± SEM.
(D) Northern blots performed on indicated RNAs.
(E) qRT-PCR analysis of the relative expression the indicated miRNAs expressed from the indicated miR-1792/ rescue plasmids. Data are normalized to
snoR142 and represented as mean ± SEM.
(F) Flag immunoprecipitation (Flag-IP) assays performed from cells expressing the indicated Flag-tagged cDNAs together the indicated miRNA expressing
plasmids. qRT-PCRwas performed on RNAs collected from the purified complexes and the relative enrichment of the pro-miRNA signal in the IP compared with
input samples is plotted for each protein.
(G) Schematic representation of the WT and the cleavage mutant luciferase reporters (top). Reporter assays in 293 cells were performed in triplicate and the
indicated siRNAs were co-transfected with the reporter plasmid DNA (bottom). *p < 0.05, **p < 0.01, versus control sample, Student’s t test.
See also Figure S4.and the U2 snRNP are specifically required for pro-miRNA
biogenesis.
To provide more evidence that splicing factors are selectively
required for miR-1792 expression, we performed rescue ex-
periments inmiR-1792 knockout ESCs.We found that whereas
DGCR8 was required for expression of miRNAs from both the
pro-miR-1792 as well as the plasmid containing pro-miR-894 Cell 162, 885–899, August 13, 2015 ª2015 Elsevier Inc.1792 with the upstream sequences (pro+50F), the splicing
factors ISY1 and SF3B1 were specifically required for the
expression of miRNAs from pro+50F (Figure 6E).
To further confirm the role of these factors in pro-miRNA
biogenesis, we affinity-purified DGCR8, CPSF3, and ISY1 con-
taining ribonucleoprotein complexes from cells and analyzed
the associated RNA by qRT-PCR. For these experiments, cells
were co-transfected with plasmids expressing the indicated
Flag-tagged protein together with plasmids expressing either
wild-type pri-miR-1792, the cleavage site mutant version of
pri-miR-1792, or the corresponding pro-miRNAs. This re-
vealed that unlike DGCR8 that associates with all the RNAs
tested, CPSF3 and ISY1 specifically associate with the cleavage
site mutant pri-miR-1792, consistent with the specific role of
these factors in pro-miRNA biogenesis (Figure 6F).
A Luciferase reporter containing the 50 region of pri-miR-
1792 was generated. Pri-miR-1792 sequences (beginning
from the start of exon 2 and ending in the pre-miR-17 hairpin)
were cloned into the 30 UTR of the Renilla luciferase gene (Fig-
ure 6G).We previously used a similar approach tomonitorMicro-
processor activity (Mori et al., 2014). We used this reporter and a
reporter containing a mutated cleavage site to examine the
effects of ISY1, SF3B1, CPSF2, and CPSF3 knockdown on the
relative luciferase values. For factors involved in cleavage of
the 50 region of pri-miR-1792, we expect to see a stabilization
of the Renilla luciferase relative to a control Firefly luciferase
upon knockdown. We found that depletion of ISY1, SF3B1,
and CPSF3, but not CPSF2, led to increased Renilla relative to
Firefly luciferase. Importantly, this effect was specific to the
wild-type pri-miR-1792 fragment since depletion of these
same factors had no stabilizing effect on the cleavage site
mutant reporter. Taken together, our data support that spliceo-
some components and the CPSF3 endonuclease subunit of
the pre-mRNA 30 processing complex, are specifically required
for cleavage of the pri-miRNA.
Pro-miRNA Biogenesis Controls miR-1792 Expression
in Embryonic Stem Cells
We considered that developmentally regulated expression of
some of these factors required for pri-miR-1792 processing
might be responsible for the dynamic miRNA expression during
ESC differentiation (Figures 1A and 1B). We measured the rela-
tive gene expression during ESC differentiation and found ISY1
expression level to be correlated with miRNA expression with a
peak at day 3 of ESC differentiation (Figures 7A and 7B). Further-
more, ISY1 expression also correlated with cleavage of the 50 re-
gion of pri-miR-1792 since primers spanning the cleavage site
(but not other regions of pri-miR-1792) showed a decline in
signal by qRT-PCR at day 3 (Figure 7C). These correlative data
suggested that ISY1 might be a limiting factor in ESCs for the
processing of certain miRNAs from pri-miR-1792. To test
this, we overexpressed ISY1 in ESCs and measured the effects
on miRNA expression. We found that ISY1 overexpression in
this context caused a selective miRNA upregulation and corre-
sponding increase in cleaved pri-miR-1792 (Figure 7D). These
results indicate that the developmentally regulated generation of
pro-miRNA is likely responsible for the posttranscriptional con-
trol of miR-1792 expression in ESCs.
Considering the developmental requirement of ISY1 for
miRNA expression and the involvement of both ISY1 and
CPSF3 in pro-miRNA biogenesis, we next examined the possible
physical and functional interaction between ISY1, CPSF3, and
the Microprocessor. ISY1 and CPSF3 were found to specifically
associate with Drosha and DGCR8 in co-immunoprecipitation
(coIP) experiments (Figures 7E and 7F). Whereas this interactionwith Microprocessor was strongly diminished by RNase treat-
ment, the interaction between ISY1 and CPSF3 complexes is
likely not mediated by RNA (Figure 7F). Functionally, we found
that addition of immunopurified Flag-ISY1 complex could
enhance the specific CPSF3-catalyzed pri-miRNA cleavage
in vitro (Figure 7G).
DISCUSSION
Here, we uncover a new paradigm formiRNA expression control.
While proteins that inhibit or promote the biogenesis of certain
miRNAs are known, our discovery that cis-acting sequences
within a pri-miRNA can selectively and dynamically regulate
expression of a miRNA cluster through the formation of an inhib-
itory RNA conformation reveals an additional posttranscriptional
mechanism for the precise control of miRNA expression. This
mechanism also allows the uncoupling of expression of individ-
ual miRNAs from within a single pri-miRNA cluster. In exploring
the mechanism of the dynamic posttranscriptional control of
pri-miR-1792 miRNA expression during ESC differentiation,
we identified a miRNA biogenesis intermediate that we termed
progenitor miRNA (pro-miRNA). Specific cleavage of an autoin-
hibitory 50 RNA fragment is required to selectively license Micro-
processor-mediated production of most pre-miRNAs from
pri-miR-1792. We employed a biochemical approach to iden-
tify possible factors involved in pro-miRNA biogenesis and
showed, using a variety of approaches, that the CPSF3 ribonu-
clease as well as the spicing factor ISY1 (and other U2 snRNP
components) are required for pro-miRNA biogenesis and selec-
tive expression of all miRNAs within the cluster except for miR-
92. We find that developmentally regulated ISY1 expression is
critical for controlling expression of miRNAs from pri-miR-
1792 during ESC differentiation.
Our identification of pro-miRNA upstream of Microprocessor
challenges the current two-step processing model for miRNA
biogenesis and adds an additional regulatory step for the post-
transcriptional control of miR-1792 expression. It will be inter-
esting to explore the more widespread relevance of pro-miRNA
intermediates in the miRNA biogenesis pathway. In this regard,
large, partially processed, pri-miRNAs have been observed in
mouse ESCs (Houbaviy et al., 2005). Our identification of two
complementary repression domains that nucleate the formation
of a repressive higher order RNA conformation to control miRNA
biogenesis might also be a relevant mechanism for the control of
other RNAs including protein-coding mRNAs. Our results also
highlight a potential limitation of in vitro Microprocessor assays
that typically utilize artificially truncated ‘‘pri-miRNAs’’ sub-
strates and therefore might miss important regulatory mecha-
nisms that exist in cells.
Our data implicate RNA conformation in the selective inhibition
of Microprocessor cleavage of pri-miR-1792. A role for RNA
tertiary structure in regulating miR-1792 has been previously
suggested (Chakraborty et al., 2012; Chaulk et al., 2011, 2014).
However, those reports deal exclusively with the miR-1792
cluster without any flanking sequences (i.e., the equivalent of
the pro-miRNA). Also, the proposed model whereby the miR-
1792 cluster adopts a globular tertiary structure with pre-
miR-19b and pre-miR-92 at the core does not correlate wellCell 162, 885–899, August 13, 2015 ª2015 Elsevier Inc. 895
Figure 7. Pro-miRNA Biogenesis Controls miR-1792 Expression in Embryonic Stem Cells
(A) qRT-PCR analysis of the indicated mRNA over a differentiation time course. Data are normalized to ACTIN and represented as mean ± SEM. **p < 0.01,
Student’s t test.
(B) Western blot analysis.
(C) qRT-PCR analysis of the relative expression of regions of the endogenous pri-miR-1792 during ESC differentiation. Primers amplifying a region spanning the
cleavage site (CS), a region in the 50 upstream sequence (50), and a region in the 30 downstream sequence (30) of pri-miR-1792were used. Data are normalized to
ACTIN and represented as mean ± SEM. *p < 0.05, Student’s t test.
(D) qRT-PCR analysis of ectopic ISY1 expression, endogenous pri-miR-1792 expression using the primers as in (C) and the endogenous miRNAs indicated.
Data are normalized to sno142 (for miRNAs) and ACTIN (for pri-miRNA) and represented as mean ± SEM. *p < 0.05, **p < 0.01, Student’s t test.
(legend continued on next page)
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with the relative abundance ofmaturemiRNAs in cells sincemiR-
19b, and/or miR-92 are often the most highly expressed mem-
bers of the cluster. The physiological relevance of this work
therefore remains unclear (Chaulk et al., 2011).
The exact mechanism and full repertoire of factors responsible
for the coupling of pri-miR-1792 transcription, recruitment of
CPSF3, ISY1, and other spliceosome subunits for the precise
cleavage of the autoinhibitory RNA fragment, and subsequent
processing by Microprocessor remain active areas of investiga-
tion. CPSF3 is known to be required for the cleavage of mRNAs
and is also involved in the generation of the 30 end of (non-
polyadenylated) histone mRNAs (Dominski et al., 2005; Mandel
et al., 2006). In the latter case, CPSF3 cleavage activity is
directed by the U7 small nuclear ribonucleoprotein (snRNP)
(Dominski et al., 2005). We find that although CPSF3 protein is
sufficient to specifically cleave pri-miR-1792 in vitro, this activ-
ity is enhanced by ISY1 complex, and ISY1 is required for pro-
miRNA biogenesis in cells. The physical association of CPSF3
with both the U1 SnRNP as well as the U2 snRNP has been re-
ported (Kyburz et al., 2006; Wassarman and Steitz, 1993). We
find a role for components of the U2 snRNP, and in particular,
a poorly characterized protein ISY1 that likely helps recruit and
direct CPSF3 activity. Furthermore pri-miR-1792 cleavage
does not lead to polyadenylation since the 50 fragment is de-
tected specifically in the polyA- RNA fraction suggesting that
these activities are uncoupled in this context. Drosha is known
to physically associate with the spliceosome yet the precise
functional relevance of this interaction is not completely under-
stood and might be variable depending on the particular pri-
miRNAs (Kataoka et al., 2009; Kim and Kim, 2007; Morlando
et al., 2008; Pawlicki and Steitz, 2010). Our model implicates
multiple protein complexes and different activities that converge
to regulate pro-miRNA biogenesis in a developmentally regu-
lated manner (Figure 7H).
This work examined the developmental regulation of miR-
1792 expression. Considering the strong links of this miRNA
cluster with numerous human malignancies it will be of great in-
terest to further explore the relevance of this control mechanism
in the context of cancer.
EXPERIMENTAL PROCEDURES
Cell Culture, ESC Differentiation, and Transfection
ESCswere cultured in DMEMwith ESGRO (1,000 units/ml), with 15% (v/v) FBS
and antibiotics. For ESC differentiation, ESGRO was removed from the media
and cells collected daily. HEK293 cells were cultured in DMEM with 15% (v/v)
FBS (Gregory et al., 2004). Lipofectamine 2000 (Invitrogen) was used for all
transfections.
Plasmids and Site-Directed Mutagenesis
cDNA of mouse pri-miR-1792 was cloned into EcoRI and XhoI sites of
pcDNA3 (Invitrogen) and as XhoI and NotI sites of psiCHECK-2 (Promega).
cDNAs of mouse ISY1 and CPSF3 were cloned into BamHI and SalI sites of
pFlag-CMV2 (Sigma) and CPSF3 cDNA was subcloned into SalI and NotI sites(E and F) Co-immunoprecipitation (coIP) assays performed by using the indicate
affinity eluate western blot using indicated antibodies. Where indicated lysates a
(G) CPSF cleavage assays with His-CPSF3 and Flag-ISY1 complex purified from
(H) Model for the posttranscriptional control of miR-1792 biogenesis.of pETDuet-1 Vector (Novagen). pFlag-CMV2-DGCR8 plasmid was described
(Gregory et al., 2004). Primers used for CRISPR/Cas9 mutagenesis were de-
signed (http://crispr.mit.edu/) and cloned into PX330 vector. Q5 Site-Directed
Mutagenesis Kit (NEB) was used for mutagenesis. All cloning primers are listed
in Table S2.
RNA Purification and Northern Blots
Total RNAwas extracted using Trizol (Invitrogen). Total RNA (200 mg) was used
for polyA(+) RNA isolation with the Dynabeads mRNA Purification Kit (Invitro-
gen) following the manufacturer’ s instructions, while the supernatant in the
step of the binding of oligo(dT) cellulose was kept and an equal volume of
isopropanol added to precipitate PolyA() RNA. PolyA(+) (200 ng), 20 mg
polyA(), and 20 mg total RNA were loaded on 15% formaldehyde-agarose
gels for large RNA northern blot. The cDNAs amplified by PCR corresponding
to the different regions of mouse pri-miR-1792 were labeled by 32P-dCTP
using DNA Polymerase I, Large (Klenow) Fragment (NEB) and used as probes.
Small RNA northern blot was performed as described (Gregory et al., 2004).
Probes and primers are listed in Table S3.
RNA Cloning and Sequencing
PolyA(+) (200 ng) RNA isolated as described above was used for mRNA-seq.
Sample preparation was with the TruSeq Stranded mRNA Sample Prep Kits
(Illumina). Small RNA-seq sample preparation was performed as previously
described (Thornton et al., 2014). Both sets of samples were subjected to
Illumina high-throughput sequencing. For the analysis of mRNA-seq data,
TopHat software was used. Bowtie software was used for the alignment of
small RNAs to mature miRNA sequences (http://www.mirbase.org/) without
any mismatches permitted.
50 RACE
50 RACE was performed on 50 ng PolyA(+) RNA and 5 mg PolyA() RNA using
the 50 RACE System (Invitrogen). Gene-specific primers were used for reverse
transcription and then cDNAs were purified and a dC-tail added using TDT.
Two rounds of PCR were performed and the amplicons were cloned into
pGEM-T Easy vector (Promega). Different clones were picked for Sanger
sequencing. Primers used for 50 RACE are listed in Table S3.
In Vitro Transcription, Microprocessor, and CPSF3 Cleavage Assays
A T7 primer and gene-specific primers were used to PCR amplify pri-miR-
1792 sequences from plasmid DNA template. PCR products were gel-
purified and used as templates for in vitro transcription using the Riboprobe
(Promega) system together with 32P-CTP for radioactive labeling. Micropro-
cessor purified from Flag-DROSHA-293 cells was used for in vitro Micropro-
cessor assays (Gregory et al., 2004). Cold RNA was produced using the
same strategy without 32P-CTP addition. For RNA annealing, 10 mM MgCl2
was added to 200 pmol cold RNA and incubated at 95C for 5 min and then
slowly cooled to reverse transcription (RT). Annealed RNA was subjected to
5% native polyacrylamide gel for ethidium bromide staining and used for
Microprocessor assay followed by small RNA northern blot analysis. His-
CPSF3 complexwas purified from E. coli as described previously for other pro-
teins (Chang et al., 2013). Assays conditions were as for Microprocessor.
CRISPR/Cas9 Mutagenesis
Oligo DNA (0.5 pmol 200 nt) corresponding to mouse pri-miR-1792
sequence containing AG / CC mutation, 12 mg PX330 plasmid containing
guide RNA sequence near the cleavage site, and 1 mg plasmid expressing
puromycin resistance gene were co-transfected into 3 million V6.5 ESCS by
nucleofection using Primary Cell Nucleofector Kits (Lonza). After 1 day, puro-
mycin was added to media. Individual ESC clones were picked and screened
by PCR and DNA sequencing.d Flag-tagged cDNAs, performing Flag-affinity purifications, and analyzing the
nd IPs were treated with RNase A.
HEK293 cells.
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Synthetic RNA Annealing
Synthetic RNA (from IDT) UUUGGCUUUUUCCUUUUUGUCUA (RD) and
UAGAGAAGUAAGGGAAAAUCAAA (RD*) were mixed in buffer (10 mM Tris,
pH 8.0, 20 mM NaCl), incubated 95C 1 min, and cooled slowly to room tem-
perature. Annealed RNA was subjected to 10% native Polyacrylamide Gel for
SYBR Gold staining (Invitrogen).
RNase T1 Accessibility Assay
In vitro transcribed RNA was subjected to annealing then incubated with
RNase T1 at 37C for 15 min. Phenol-chloroform was used to isolate the
RNA, followed by isopropanol precipitation. Superscript III Reverse Transcrip-
tase (Invitrogen) was used to synthesize cDNA. Pri-miR-1792-specific
primers were labeled using 32P-ATP T4 and polynucleotide kinase (NEB), fol-
lowed by Microspin G-50 Columns (GE Healthcare) and products of primer
extension subjected to 15% TBE-Urea Polyacrylamide Gel electrophoresis.
Primers are listed in Table S3.
Electron Microscopy
RNAs were transcribed using AmpliScribe T7 High Yield Transcription Kit.
Transcribed RNAs were gel purified (8% urea polyacrylamide gel). Purified
RNA samples were supplemented with 10 mM sodium cacodylate pH 6.8,
then heated to 90C for 30 s and slowly cooled to room temperature. The
annealed RNA samples were incubated with 10 mM MgCl2 for 20 min. RNA
(2 ml) of 200 ng/ml sample was applied to glow discharged carbon-coated
grids. Grids were stained with 2% uranyl acetate. The EM micrographs were
collected on a Tecnai G2 Spirit BioTWIN with Hamamatsu ORCA-HR C4742-
95-12HR detector at magnification of 49,0003. Image processing and particle
picking was performed using EMAN2 (Tang et al., 2007). Five hundred parti-
cles were included for all analysis. Scikit-image was used to measure the
diameter and circularity of particles. The results were then plotted using
matplotlib.
CoIP and Western Blots
V6.5 ESCs were transfected with pFlag-CMV2 vector expressing AGO2, ISY1,
CPSF3, or DGCR8 cDNAs. Cell lysis and coIPs were performed as described
before (Mori et al., 2014) and analyzed by western blot using a-Flag (Sigma),
a-Drosha (Cell Signaling), a-ISY1 (Abcam), a-CPSF3 (Abcam), and a-CPSF2
(Abcam) antibodies.
Immunoprecipitation and qRT-PCR
HEK293 cells were transfected with pFlag-CMV2 vectors expressing ISY1,
CPSF3, or DGCR8. After UV cross-linking, lysates were collected with NETN
buffer as described before (Mori et al., 2014). One-tenth of each cell lysate
was used for RNA extraction using Trizol reagent (Invitrogen), and the rest
was incubated with Anti-Flag M2 Affinity Gel (Sigma-Aldrich) at 4C overnight.
Anti-Flag M2 Affinity Gel was then washed five times using NETN buffer and
before RNA extraction with Trizol reagent and analysis by qRT-PCR.
RNA-Affinity Purification and Mass Spectrometry
In vitro-transcribed cold RNAwas conjugated to agarose beads and incubated
withwhole-cell extract fromV6.5 ES cells, and the affinity eluate was subjected
to SDS-PAGE followed by Coomassie blue staining. Bands were excised and
subjected to mass spectrometric sequencing as described before (Chang
et al., 2013).
Luciferase Reporter Assays
Dgcr8/ ESCs were co-transfected with psiCHECK-2 vectors containing
mouse pri-miR-1792 with the indicated siRNA sequences using Lipofect-
amine 2000 (Invitrogen). After 2 days of transfection, cells were collected
and Passive Lysis Buffer (Promega) added and incubated at RT for 20 min.
Dual-Luciferase Reporter Assay System (Promega) was used to measure the
Renilla and Firefly activity.
mRNA and miRNA by qRT-PCR
For mRNA analysis, 3 mg total RNA was treated with DNase (Promega) for 2 hr
to remove genomic DNA. Superscript III Reverse Transcriptase (Invitrogen)
and random primers were used to synthesize cDNA, and IQ SYBR Green898 Cell 162, 885–899, August 13, 2015 ª2015 Elsevier Inc.Supermix (Bio-Rad) was used to quantify the cDNA. For miRNA analysis,
10 ng total RNA was used. Taqman probes and Universal PCR master mix
(Applied Biosystems) were used for cDNA detection. All the primers used for
qPCR were listed in Table S4.
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